Dr. Sara Dugan shares her knowledge of this topic with the SOC FOR MSY Project ECHO session on May 13, 2021.
Tag: weight
Nutrition Assessment in Complex Needs – Systems of Care ECHO for Multi-System Youth
Marissa Testa, MS, RDN, CSP, LD, from Nationwide Children’s Hospital shares her knowledge of this topic with the SOC FOR MSY Project ECHO session on April 8, 2021.
What are the risks of Lithium and How to use it safely?
In this lecture, Dr. Dugan takes a look at the risk profile of lithium and discusses ways to use it safely. By the end of this lecture, you will be able to: 1) list the indications for use of lithium, 2) identify short- and long-term adverse effects associated with lithium use, and 3) compare monitoring recommendations for patients on lithium.
Tricyclic Antidepressants: An Overview
In this lecture, Dr. Dugan discusses the tricyclic antidepressants including their mechanism of action, indications, dosing, monitoring, and common side effects. By the end of this lecture, you will be able to: 1) describe the pharmacology of the tricyclic antidepressants (TCA), 2) identify relevant pharmacokinetic differences between TCAs, and 3) evaluate the literature on TCAs for the treatment of depression.
Metformin in Psychiatric Practice
In this lecture, Dr. Dugan briefly reviews the pharmacology of metformin and describes studies that look at the potential uses for metformin in psychiatric practice. By the end of this lecture, you will be able to: 1) describe the pharmacology of metformin, 2) identify potential uses of metformin in the mental health field, and 3) outline a monitoring plan for patients on metformin.
Pharmacodynamics: How do antipsychotic medications work?
In this lecture, Dr. Dugan reviews the mechanisms of action of the medications used to treat psychosis. By the end of this lecture, you will be able to: 1) identify common pharmacologic targets of first and second generation antipsychotic medications, 2) describe proposed therapeutic actions of first and second generation antipsychotic medications, and 3) compare adverse effect profiles of the first and second generation antipsychotic medications.
